DACOPLICE 45MG TABLET

Form: Tablets

Pack Size: 30 TABLETS

Marketed by: PFIZER PRODUCTS INDIA PVT LTD (ONCOLOGY DIV)

MRP: ₹63984.38

PFIZER PRODUCTS INDIA PVT LTD (ONCOLOGY DIV): Dacoplice 45MG Tablet, 30 tablets, salt dacomitinib 45mg. Its MRP stays at Rs 63,984.38 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 48,750. Group: EGFR tyrosine kinase inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: avoid acid-reducing PPIs; check co-prescriptions. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.